Dr. Patterson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
PRW Laboratories
2331 Seminole Lane, Suite 102
Charlottesville, VA 22901Phone+1 434-244-0162Fax+1 434-244-0153
Summary
- Dr. James Patterson is a dermatologist in Charlottesville, VA and is Professor Emeritus of Pathology at the University of Virginia Medical Center. He received his medical degree from Virginia Commonwealth University School of Medicine and has been in practice 45 years. He specializes in dermatopathology and is experienced in dermatopathology and complex medical dermatology. He practices dermatopathology part time.
Education & Training
- Armed Forces Institute of PathologyFellowship, Dermatopathology, 1979 - 1980
- Virginia Commonwealth University Health SystemResidency, Dermatology, 1973 - 1976
- Virginia Commonwealth University School of MedicineClass of 1972, MD
Certifications & Licensure
- SC State Medical License 2017 - 2025
- WV State Medical License 2018 - 2025
- AL State Medical License 2010 - 2024
- NC State Medical License 2008 - 2024
- NY State Medical License 1978 - 2024
- VA State Medical License 1973 - 2024
- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
Awards, Honors, & Recognition
- Founders Award American Society of Dermatopathology, 2018
- Elson B. Helwig Memorial Lecturer American Society of Dermatopathology, 2018
- Alpha Omega Alpha 2016
- Join now to see all
Publications & Presentations
PubMed
- 79 citationsProliferating pilar tumors: a clinicopathologic study of 76 cases with a proposal for definition of benign and malignant variants.Jay Ye, Oscar Nappi, Paul E. Swanson, James W. Patterson, Mark R. Wick
American Journal of Clinical Pathology. 2004-10-01 - 26 citationsCutaneous paraneoplastic syndromes.Mark R. Wick, James W. Patterson
Seminars in Diagnostic Pathology. 2019-07-01 - 178 citationsPhase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.Craig L. Slingluff, Galina V. Yamshchikov, Patrice Y. Neese, Holly Galavotti, Shannon Eastham
Clinical Cancer Research. 2001-10-01
Professional Memberships
- Fellow
- Fellow
- American Society of DermatopathologyLife Member
- Royal Society of MedicineMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: